Radiation-sparing managements for cervical cancer: A developing countries perspective

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Candelaria, Myrna ^a   Cetina, Lucely ^a   Garcia Arias, Alicia ^a   Lopez Graniel, Carlos ^a   de la Garza, Jaime ^a   Robles, Elizabeth ^a   Duenas Gonzales, Alfonso ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CAMPTOTHECIN DERIVATIVE; CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; IRINOTECAN; NAVELBINE; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX; RADIOSENSITIZING AGENT; TAXANE DERIVATIVE; VINCRISTINE;

ADJUVANT THERAPY; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYSTIC LYMPHANGIOMA; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; DRUG FATALITY; FISTULA; GASTROINTESTINAL TOXICITY; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HIGH RISK POPULATION; HUMAN; HYDRONEPHROSIS; HYSTERECTOMY; META ANALYSIS; MONOTHERAPY; OVERALL SURVIVAL; PELVIC DISEASE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; QUALITY OF LIFE; RADIATION DOSE; RECTUM CANCER; RESOURCE MANAGEMENT; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

EID: 33845389613     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-77     Document Type: Review

References (74)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Dueñas-Gonzalez A, Cetina L, Mariscal I, de la Garza J: Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003, 29:389-399.
3. Sankaranarayanan R, Budukh AM, Rajkumar R: Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001, 79:954-962.
4. Gershenson DM: Fertility-sparing surgery for malignancies in women. J Natl Cancer Inst Monogr 2005, 34:43-47.
5. Plante M, Renaud MC, Roy M: Radical vaginal trachelectomy: a fertility-preserving option for young women with early stage cervical cancer. Gynecol Oncol 2005, 99(3 Suppl 1):S143-S146.
6. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 1999, 73:177-183.
7. Peters WA 3rd, Liu PY, Barrett R, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P. Gordon W Jr, Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18:1606-1613.
8. National Institutes of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol 1997, 66:351-361.
9. Green JA, Kirwan JM, Tierney JF: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001, 358:781-786.
10. Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, Williams C, Collingwood M: Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005:CD002225.
11. King M, McConkey C, Latief TN, Hartley A, Fernando I: Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006, 18:38-45.
12. Cetina L, Rivera L, Hinojosa J, Poitevin A, Uribe J, López-Graniel C, Cantú D, Candelaria M, de la Garza J, Dueñas-González A: Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. BMC Women's Health 2006, 6:3.
13. Candelaria M, Garcia-Arias A, Cetina L, Duenas-Gonzalez A: Radio-sensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006, 1:15.
14. Levin V, Meghzifene A, Izewska J, Tatsuzaki H: Improving cancer care. Increased need for radiotherapy In developing countries. IAEA BULLETIN, 43/2/2001 [http://www.iaea.org./Publications/Magazines/Bulletin/Bull432/ article6.pdf]. [Last accessed on 1, August 2006]
15. Tatsuzaki H, Levin CV: Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol 2001, 60:81-89.
16. Zubizarreta EH, Poitevin A, Levin CV: Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol 2004, 73:97-100.
17. Newton M: Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975, 123:535-542.
18. Morley GW, Seski JC: Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976, 126:785-798.
19. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997, 350:535-540.
20. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ: A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006, 65:169-176.
21. Suprasert P, Srisomboon J, Kasamatsu T: Radical hysterectomy for stage IIB cervical cancer: a review. Int J Gynecol Cancer 2005, 15:995-1001.
22. Kamura T, Tsukamoto N, Tsuruchi N, Kaku T, Saito T, To N, Akazawa K, Nakano H: Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection - an analysis with mathematical statistics. Int J Gynecol Cancer 1993, 3:219-225.
23. Höckel M: Pelvic recurrences of cervical cancer. Relapse pattern, prognostic factors and the role of extended radical treatment. J Pelv Surg 1999, 5:255-266.
24. Heald RJ, Husband EM, Ryall RDH: The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982, 69:613-616.
25. Enker WE: Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992, 127:1396-402.
26. Höckel M, Konerding MA, HeuBel CP: Liposuction-assisted nerve-sparing extended radical hysterectomy. Oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol 1998, 178:971-976.
27. Höckel M: Totale mesometriale Resektion: Nervenschonende erweitert radikale abdominale Hysterektomie. Zentralbl Gynäkol 2001, 123:245-249.
28. Höckel M, Naumann G, Hentschel B, Horn L-C, Höckel S: Total mesometrial resection - nerve-sparing extended radical hysterectomy. Surgical techniques and results of a 3-year prospective study [abstract]. Gynecol Oncol 2002, 84:490.
29. Williams PL, Warwick R, Dyson M, Bannister LH: Gray's Anatomy. 37th edition. New York Churchill Livingstone; 1989.
30. Fritsch H: The connective tissue sheath of uterus and vagina in the human female fetus. Ann Anat 1992, 174:261-266.
31. Hockel M, Horn LC, Hentschel B, Hockel S, Naumann G: Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy. Int J Gynecol Cancer 2003, 13:791-803.
32. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003, 39:2470-2486.
33. Sardi J, Sananes C, Giaroli A: Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer 1998, 8:441-450.
34. Sardi J, Giaroli A, Sananes C: Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: An unexpected therapeutic management. Int J Gynecol Cancer 1996, 6:85-93.
35. Kigawa J, Minagawa Y, Ihshihara H, Itamochi H, Kanamori Y, Terakawa N: The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 1996, 19:255-259.
36. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C, Landoni F: Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer. Results from the Italian Multicenter Randomized Trial. J Clin Oncol 2002, 20:179-188.
37. Eddy GL: Neoadjuvant chemotherapy before surgery in cervical cancer. J Natl Cancer Inst Monogr 1996, 21:93-96.
38. Zanetta G, Lissoni A, Pellegrino A, Sessa C, Colombo N, Gueli-Alletti D, Mangioni C: Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998, 9:977-980.
39. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, Cetina L, Rivera L, Mariscal I, Montalvo G, Gómez E, De la Garza J, Chanona G, Mohar A: A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003, 14:1278-1284.
40. Sugiyama T, Nishida T, Kumagai S, Nishio S, Fujiyoshi K, Okura N, Yakushiji M, Hiura M, Umesaki N: Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer 1999, 81:95-98.
41. Pignata S, Silvestro G, Ferrari E, Selvaggi L, Perrone F, Maffeo A, Frezza P, Di Vagno G, Casella G, Ricchi P, Cormio G, Gallo C, Iodice F, Romeo F, Fiorentino R, Fortuna G, Tramontana S: Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999, 17:756-760.
42. Duenas-Gonzalez A, Lopez-Graniel C, González A, Reyes M, Mota A, Muñoz D, Solorza G, Hinojosa LM, Guadarrama R, Florentino R, Mohar A, Melendez J, Maldonado V, Chanona J, Robles E, De la Garza J: A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001, 12:541-547.
43. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez A, Gomez E, Rivera L, Mohar A, Chanona G, Trejo-Becerril C, de la Garza J: Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol 2003, 26:22-25.
44. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, Mohar A, Rivera L, Mota A, Guadarrama R, Chanona G, De La Garza J: Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Ann Oncol 2002, 13:1212-1219.
45. Duenas-Gonzalez A, Lopez-Graniel CM, Mota A, Mohar A: Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma. J Clin Oncol 2002, 20:2908-2909.
46. Duenas-Gonzalez A, Rivera L, Mota A, Lopez-Graniel C, Guadarrama A, Gonzalez A, Chanona G, Cabrera P, de la Garza J: The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma. Arch Med Res 2002, 33:201-202.
47. Pisters PW, Ballo MT, Patel SR: Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol 2002, 9:535-542.
48. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS: T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002, 45:895-903.
49. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185:538-543.
50. Vora SA, Daly BD, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S, Dipetrillo TA: High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 2000, 89:1946-1952.
51. Keys HM, Bundy BN, Stehman FB, Okagaki T, Gallup DG, Burnett AF, Rotman MZ, Fowler WC Jr: Gynecologic Oncology Group. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003, 89:343-353.
52. Monk BJ, Solh S, Johnson MT, Moritz FJ: Radical hysterectomy after pelvic irradiation in patients with high risk cervical cancer or uterine sarcoma: morbidity and outcome. Eur J Gynaecol Oncol 1993, 14:506-511.
53. Jurado M, Martinez-Monge R, Garcia-Foncillas J, Azinovic I, Aristu J, Lopez-Garcia G, Brugarolas A: Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol 1999, 74:30-37.
54. Mancuso S, Smaniotto D, Benedetti-Panici P, Favale B, Greggi S, Manfredi R, Margariti PA, Morganti AG, Scambia G, Tortoreto F, Valentini V, Cellini N: Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 2000, 78:324-328.
55. Bernard A, Touboul E, Lefranc JP, Deniaud-Alexandre E, Genestie C, Uzan S, Blondon J: [Epidermoid carcinoma of the uterine cervix at operable bulky stages IB and II treated with combined primary radiation therapy and surgery]. Cancer Radiother 2002, 6:85-98.
56. Moyses HM, Morrow CP, Muderspach LI, Roman LD, Vasilev SA, Petrovich Z, Groshen SL, Klement V: Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol 1996, 19:433-438.
57. Rouzier R, Morice P, De Crevoisier R, Pomel C, Rey A, Bonnet K, Recoules-Arche A, Duvillard P, Lhomme C, Haie-Meder C, Castaigne D: Survival in cervix cancer patients treated with radiotherapy followed by radical surgery. Eur J Surg Oncol 2005, 31:424-433.
58. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL, Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
59. Noterman D, Philippson C, Hertens D, Veys I, Schobbens JC, Nogaret JM: [Neoadjuvant radiochemotherapy and surgery of locally advanced cervical carcinoma: review of 22 patients treated at the Bordet Institute]. J Gynecol Obstet Biol Reprod (Paris) 2006, 35:23-27.
60. Resbeut M, Cowen D, Viens P, Noirclerc m, Perez T, Gouvernet J, Delpero JR, Gamerre M, Boubli L, Houvenaeghel G: Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 1994, 54:68-75.
61. Houvenaeghel G, Lelievre L, Rigouard AL, Buttarelli M, Jacquemier J, Viens P, Gonzague-Casabianca L: Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006, 102:74-79.
62. Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, Houvenaeghel G: Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol 2006, 102:523-529.
63. Modarress M, Maghami FQ, Golnavaz M, Behtash N, Mousavi A, Khalili GR: Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer 2005, 15:483-488.
64. Mariagrazia D, Anna F, Gabriella F, Francesco F, Daniela S, Giuseppe D, Alessio M, Giovanni S: Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol 2005, 99(3 Suppl 1):S166-170.
65. Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, O'Donoghue DP, Moriarty M, Fennelly D, Sheahan K: Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005, 47:141-146.
66. Trodella L, Granone P, Valente S, Margaritora S, Macis G, Cesario A, D'Angelillo RM, Valentini V, Corbo GM, Porziella V, Ramella S, Tonini G, Galetta D, Ciresa M, Vincenzi B, Cellini N: Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to down-staging. Ann Oncol 2004, 15:389-398.
67. Splinter TA, Scher HI, Denis L, Bukowski R, Simon S, Klimberg I, Soloway M, Vogelzang NJ, van Tinteren H, Herr H: The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer - Genitourinary Group. J Urol 1992, 147:606-608.
68. Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F: Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 2002, 86:1041-1046.
69. Candelaria M, Chanona-Vilchis J, Cetina L, Flores-Estrada D, Carlos López-Graniel C, González-Enciso A, Cantú D, Poitevin A, Rivera L, Hinojosa J, de la Garza J, Dueñas-Gonzalez A: Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol 2006, 3:3.
70. Duenas-Gonzalez A, Cetina-Perez L, Lopez-Graniel C, Gonzalez-Enciso A, Gomez-Gonzalez E, Rivera-Rubi L, Montalvo-Esquivel G, Munoz-Gonzalez D, Robles-Flores J, Vazquez-Govea E, de La Garza J, Mohar A: Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study. Int J Radiat Oncol Biol Phys 2005, 61:817-823.
71. Dargent D, Lamblin G, Romestaing P, Montbarbon X, Mathevet P, Benchaib M: Effect of radiotherapy on pelvic lymph node metastacis in cervical cancer stages IB2-IVA: a retrospective analysis of two comparative series. Int J Gynecol Cancer 2005, 15:468-474.
72. Orr JW, Shingleton HM, Hatch KD: Correlation of perioperative morbidity and conization to radical hysterectomy interval. Obstet Gynecol 1982, 59:726-731.
73. Hatch KD, Parham G, Shingleton H: Ureteral strictures and fistulae following radical Wertheim hysterectomy. Gynecol Oncol 1984, 19:17-23.
74. Lopez-Graniel CM, Reyes M, Chanona G, Gonzalez A, Robles E, Mohar A, Lopez-Basave H, De La Garza JG, Duenas-Gonzalez A: Type III radical histerectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer 2001, 11:210-217.